Thymidylate Synthase and Folyl-Polyglutamate Synthase Are Not Clinically Useful Markers of Response to Pemetrexed in Patients with Malignant Pleural Mesothelioma-Reference-Cited by-同舟云学术

Thymidylate Synthase and Folyl-Polyglutamate Synthase Are Not Clinically Useful Markers of Response to Pemetrexed in Patients with Malignant Pleural Mesothelioma

Published:2013-04 Issue:4 Volume:8 Page:469-477
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Lustgarten Daniel E. Schwed,Deshpande Charuhas,Aggarwal Charu,Wang Liang-Chuan,Saloura Vassiliki,Vachani Anil,Wang Li-Ping,Litzky Leslie,Feldman Michael,Creaney Jeanette,Nowak Anna K.,Langer Corey,Inghilleri Simona,Stella Giulia,Albelda Steven M.

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference20 articles.

1. Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma;Vogelzang;J Clin Oncol,2003

2. Pemetrexed: a multitargeted antifolate;Rollins;Clin Ther,2005

3. Changes in the status of p53 affect drug sensitivity to thymidylate synthase (TS) inhibitors by altering TS levels;Giovannetti;Br J Cancer,2007

4. Characterization of a thymidylate synthase (TS)-inducible cell line: a model system for studying sensitivity to TS- and non-TS-targeted chemotherapies;Longley;Clin Cancer Res,2001

5. Induction of resistance to the multitargeted antifolate Pemetrexed (ALIMTA) in WiDr human colon cancer cells is associated with thymidylate synthase overexpression;Sigmond;Biochem Pharmacol,2003

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of single nucleotide polymorphisms of the folylpolyglutamate synthase gene on pemetrexed administration‐induced nephropathy;British Journal of Clinical Pharmacology;2023-08-07

2. New Markers for Management of Mesothelioma;Seminars in Respiratory and Critical Care Medicine;2023-05-30

3. A Case of Malignant Pleural Mesothelioma Recurring 10 Years After a Long-term Response to Chemotherapy;Haigan;2023-02-20

4. Heterogeneous RNA editing and influence of ADAR2 on mesothelioma chemoresistance and the tumor microenvironment;Molecular Oncology;2022-10-31

5. Heterogeneity of RNA editing in mesothelioma and how RNA editing enzyme ADAR2 affects mesothelioma cell growth, response to chemotherapy and tumor microenvironment;2022-07-13